Union Health Ministry directs states to restrict stem cell therapy for autism to clinical trials
In response to ongoing regulatory scrutiny regarding care for autistic individuals, the Union Health Ministry has issued an advisory to all states and Union Territories mandating that stem cell therapy for autism be restricted to approved clinical trials, prohibiting its routine use as standard clinical care.
Explanation in simple terms
- What:
- The government is banning the use of stem cell therapy for autism as a regular medical treatment.
- Who:
- The Union Health Ministry issued the rule for states and Union Territories following a case involving Action for Autism.
- When:
- Reported on 17 Sep 2026.
- Where:
- Supreme Court of India.
- Why:
- The Ministry acted due to ongoing regulatory concerns about how autistic individuals receive care.
- What it means:
- Stem cell therapy for autism is now only allowed if it is part of an approved clinical trial.
Discussion
No comments yet.
Follow this case to join the discussion.